Search

everythinglearnresearchcommunity

for

Search:↓

Wedelolactone selectively kills prostate cancer cells without harming normal cells.

Mitoxantrone with a corticosteroid helps manage symptoms for some advanced prostate cancer patients but doesn't extend life.

Breast cancer treatments work better with AR activation, improving results and reducing side effects.

Medical castration in prostate cancer patients can increase the risk of serious heart rhythm problems, so it's important to monitor heart activity during treatment.

Photodynamic therapy successfully treated skin cancer in a 53-year-old woman.

DHT in the human prostate is produced through multiple pathways, not just from testosterone.

Inactive hair follicle stem cells help prevent skin cancer.

5α-reductase inhibitors may lower the risk of death from bladder cancer.

The link between anabolic agents and colorectal cancer risk is unclear.

sPLA2-IIA increases growth in hair follicle stem cells and cancer cells, suggesting it could be targeted for hair growth and cancer treatment.

Increased methylation of the Filip1l gene may contribute to aggressive skin cancer.

Diabetes may lower the risk of prostate cancer.

Low-dose DMSO may help treat castration-resistant prostate cancer by reducing key cancer cell receptors.

Treatment restored normal sexual characteristics and blood condition in a patient with testicular cancer.

Circadian rhythm disruption, chronic inflammation, hormones, metabolism, and genetics may increase prostate cancer risk.

No link was found between hair patterns and prostate cancer risk in South Indian men.

Higher BMI and lower testosterone are linked to more aggressive prostate cancer.

High DKK1 levels predict worse survival in head and neck cancer.

Plant-based compounds might be a promising alternative for prostate cancer treatment with fewer side effects.

Phytochemicals may offer safer alternatives to synthetic drugs for prostate cancer treatment.

More research is needed to understand how adipose-derived stem cells affect liver cancer treatment.

Targeting lipid metabolism can help treat advanced, resistant cancers.

20(S)-Protopanaxadiol-aglycone may help prevent and treat prostate cancer by reducing androgen receptor activity.

Androgen-modulating drugs do not significantly change the heat sensitivity of prostate cancer cells.

Finasteride reduces PSA levels, terazosin doesn't affect them, and tracking prostate cancer in patients taking finasteride could be difficult.

Finasteride reduces PSA levels, terazosin doesn't affect them, and tracking prostate cancer in patients taking finasteride could be difficult.

Connarus semidecandrus Jack extract promotes hair growth and thickness, reduces prostate cancer cell growth, and could potentially be used as a treatment for hair loss.

Prostate cancer prevention now focuses on healthy diets and some medications, not vitamins.

Testosterone treatment for older men can have short-term benefits, but long-term risks are unclear, requiring careful evaluation and monitoring.

Men with low testosterone should be carefully evaluated and monitored before and during treatment.